Statements (19)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:government_agency
|
| gptkbp:country |
gptkb:Japan
|
| gptkbp:established |
2004
|
| gptkbp:fullName |
gptkb:Pharmaceuticals_and_Medical_Devices_Agency
|
| gptkbp:headquartersLocation |
gptkb:Tokyo,_Japan
|
| https://www.w3.org/2000/01/rdf-schema#label |
PMDA
|
| gptkbp:parentOrganization |
gptkb:Ministry_of_Health,_Labour_and_Welfare_(Japan)
|
| gptkbp:responsibleFor |
adverse event reporting
regulation of medical devices post-marketing surveillance drug safety regulation of pharmaceuticals regulation of regenerative medicine products |
| gptkbp:website |
https://www.pmda.go.jp/
|
| gptkbp:bfsParent |
gptkb:baloxavir_marboxil
gptkb:Pharmaceuticals_and_Medical_Devices_Agency gptkb:Drug_Development gptkb:独立行政法人医薬品医療機器総合機構 |
| gptkbp:bfsLayer |
6
|